Modern Healthcare News
 
RSS feed

Genentech news and information

News
HHS fights back to keep expanded 340B drug discounts
By Jaimy Lee | June 12, 2014 | Basic Web Basic Web Subscription Details
The drug industry scored a victory last month against the Obama administration's plans to give hospitals millions of dollars in discounts through the 340B program on orphan drugs. But HHS is sticking to its position that the Patient Protection and Affordable Care Act promises breaks on the...
FULL STORY »
 

Information
Lung cancer screening could cost Medicare billions
By Associated Press | May 15, 2014
Every person covered by Medicare would shell out an additional $3 a month if the government agreed to pay to screen certain current and former smokers for lung cancer, a new study estimates.
FULL STORY »
 

Magazine
Letters to the Editor: CEO's contract can reveal a hospital's true mission
By Modern Healthcare | May 10, 2014 | Print Magazine Print Magazine Subscription Details
We believe that if you want to understand what a hospital's primary mission truly is—financial performance or quality patient care—you should skip the mission statement and go directly to the CEO's contract.
FULL STORY »
 

News
Google launches health company Calico
By Associated Press | September 18, 2013 | Basic Web Basic Web Subscription Details
Google says it has launched a new health company, called Calico, that will focus on aging and related diseases.
FULL STORY »
 

News
House Democrats want tougher drug-tracking legislation
By Jonathan Block | June 04, 2013 | Basic Web Basic Web Subscription Details
A U.S. House-passed bill to establish a national system for tracking pharmaceutical drugs through the supply chain to thwart counterfeit medicines faces opposition from some Democrats, who say they want a tougher bill.
FULL STORY »
 


Advertisement | View Media Kit

Information
Cancer drug Avastin doesn't extend life for newly diagnosed brain tumor patients, studies find
By Marilynn Marchione / Associated Press | June 02, 2013
New research raises fresh questions about which cancer patients benefit from Avastin, a drug that lost its approval for treating breast cancer nearly two years ago.
FULL STORY »
 

Magazine
CEO jackpot | Industry executives continue to see big payouts despite spending declines and cost-cutting
By Melanie Evans | May 11, 2013 | Print Magazine Print Magazine Subscription Details
Regeneron Pharmaceuticals had a breakthrough year in 2012, and its top scientist, Dr. George Yancopoulos, led Modern Healthcare's list of the health industry's highest-paid execs for the year.
FULL STORY »
 

Magazine
Outliers: Breakthrough Prize winners make a splash
By Modern Healthcare | February 23, 2013 | Print Magazine Print Magazine Subscription Details
The Breakthrough Prize in Life Sciences may not be the Nobel Prize, but the 11 inaugural winners aren't likely to complain. The researchers and scientists honored last week each get $3 million, more than twice the cash that comes with the Nobel Prize for medicine or physiology.
FULL STORY »
 

Information
FDA warns doctors of counterfeit Botox
By Associated Press | December 25, 2012
Federal regulators have warned more than 350 medical practices that Botox they may have received from a Canadian supplier is unapproved and could be counterfeit or unsafe.
FULL STORY »
 

News
Doyle named to CFO post at Castlight
By Melanie Evans | November 15, 2012 | Basic Web Basic Web Subscription Details
Castlight Health, a health benefits software company, named John Doyle to the newly created role of CFO.
FULL STORY »
 

Search ModernHealthcare.com:


 

Switch to the new Modern Healthcare Daily News app

For the best experience of ModernHealthcare.com on your iPad, switch to the new Modern Healthcare app — it's optimized for your device but there is no need to download.